BioCentury | May 28, 2012
Finance

AbbVie earlier

...AbbVie earlier Early stage investor Abbott Biotech Ventures will start investing even earlier after parent company Abbott Laboratories...
...of venture investment, Steven Kuemmerle, said at last week's C21 BioVentures conference in Napa, Calif. Abbott Biotech Ventures...
...nutritional businesses and retain Abbott's name. The split is expected to complete by year end. Abbott Biotech Ventures...
BioCentury | May 28, 2012
Finance

Carried away

...Among his prior positions, he was a VC with Atlas Ventures . Steven Kuemmerle of Abbott Biotech Ventures...
BioCentury | Feb 13, 2012
Company News

Abbott management update

...Abbott Laboratories (NSYE:ABT), Abbott Park, Ill. Business: Finance Retiring: Jim Tyree as president of Abbott's Abbott Biotech Ventures...
BioCentury | Feb 13, 2012
Finance

Biotech investor, banker and analyst personnel changes

...Venture tracks James Tyree is retiring as president of Abbott Biotech Ventures Inc. , a venture capital arm...
BioCentury | Jan 9, 2012
Financial News

NeuroGenetic Pharmaceuticals completes venture financing

...Del Mar, Calif. Business: Neurology Date completed: 1/4/12 Type: Venture financing Raised: Not disclosed Investor: Abbott Biotech Ventures WIR...
BioCentury | Jan 2, 2012
Financial News

AuraSense completes venture financing

...Evanston, Ill. Business: Genomics Date completed: 12/22/11 Type: Venture financing Raised: Not disclosed Investors: Abbott Biotech Ventures...
BioCentury | Dec 23, 2011
Financial News

AuraSense closes series B round

...raised an undisclosed amount in a series B round. Investors included Abbott Laboratories (NYSE:ABT) subsidiary Abbott Biotech Ventures...
BioCentury | Oct 10, 2011
Financial News

Creabilis completes venture financing

...Inflammation, Autoimmune, Dermatology Date completed: 10/4/11 Type: Venture financing Raised: €15 million ($20 million) Investors: Abbott Biotech Ventures...
BioCentury | Oct 5, 2011
Financial News

Creabilis raises EUR 15 million

...Luxembourg, Luxembourg) raised EUR 15 million ($20 million) in a series B round led by Abbott Biotech Ventures...
BioCentury | Jun 28, 2010
Emerging Company Profile

Arreseto: Blocking Fibroblasts

...raised: Undisclosed Investors: Kleiner Perkins Caufield & Byers, HealthCare Ventures, Northgate Capital, DAG Ventures and Abbott Biotech Ventures...
Items per page:
1 - 10 of 11
BioCentury | May 28, 2012
Finance

AbbVie earlier

...AbbVie earlier Early stage investor Abbott Biotech Ventures will start investing even earlier after parent company Abbott Laboratories...
...of venture investment, Steven Kuemmerle, said at last week's C21 BioVentures conference in Napa, Calif. Abbott Biotech Ventures...
...nutritional businesses and retain Abbott's name. The split is expected to complete by year end. Abbott Biotech Ventures...
BioCentury | May 28, 2012
Finance

Carried away

...Among his prior positions, he was a VC with Atlas Ventures . Steven Kuemmerle of Abbott Biotech Ventures...
BioCentury | Feb 13, 2012
Company News

Abbott management update

...Abbott Laboratories (NSYE:ABT), Abbott Park, Ill. Business: Finance Retiring: Jim Tyree as president of Abbott's Abbott Biotech Ventures...
BioCentury | Feb 13, 2012
Finance

Biotech investor, banker and analyst personnel changes

...Venture tracks James Tyree is retiring as president of Abbott Biotech Ventures Inc. , a venture capital arm...
BioCentury | Jan 9, 2012
Financial News

NeuroGenetic Pharmaceuticals completes venture financing

...Del Mar, Calif. Business: Neurology Date completed: 1/4/12 Type: Venture financing Raised: Not disclosed Investor: Abbott Biotech Ventures WIR...
BioCentury | Jan 2, 2012
Financial News

AuraSense completes venture financing

...Evanston, Ill. Business: Genomics Date completed: 12/22/11 Type: Venture financing Raised: Not disclosed Investors: Abbott Biotech Ventures...
BioCentury | Dec 23, 2011
Financial News

AuraSense closes series B round

...raised an undisclosed amount in a series B round. Investors included Abbott Laboratories (NYSE:ABT) subsidiary Abbott Biotech Ventures...
BioCentury | Oct 10, 2011
Financial News

Creabilis completes venture financing

...Inflammation, Autoimmune, Dermatology Date completed: 10/4/11 Type: Venture financing Raised: €15 million ($20 million) Investors: Abbott Biotech Ventures...
BioCentury | Oct 5, 2011
Financial News

Creabilis raises EUR 15 million

...Luxembourg, Luxembourg) raised EUR 15 million ($20 million) in a series B round led by Abbott Biotech Ventures...
BioCentury | Jun 28, 2010
Emerging Company Profile

Arreseto: Blocking Fibroblasts

...raised: Undisclosed Investors: Kleiner Perkins Caufield & Byers, HealthCare Ventures, Northgate Capital, DAG Ventures and Abbott Biotech Ventures...
Items per page:
1 - 10 of 11